Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe?
Denise Rossato Silva, Fernanda Carvalho de Queiroz Mello, Lia D’Ambrosio, Rosella Centis4, Margareth Pretti Dalcolmo, Giovanni Battista Migliori
Abstract
On April 1st, 2020, COVID-19 surpassed tuberculosis regarding the number of deaths per day worldwide. The combination of tuberculosis and COVID-19 has great potential for morbidity and mortality. In addition, the COVID-19 pandemic has had a significant impact on the diagnosis and treatment of tuberculosis. In this review article, we address concurrent tuberculosis and COVID-19, with particular regard to the differences between Brazil and Europe. In addition, we discuss priorities in clinical care, public health, and research.
Topics & Concepts
MedicineTuberculosisCoronavirus disease 2019 (COVID-19)Pandemic2019-20 coronavirus outbreakPublic healthSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Environmental healthVirologyInternal medicinePathologyDiseaseOutbreakInfectious disease (medical specialty)COVID-19 Clinical Research StudiesTuberculosis Research and EpidemiologyCOVID-19 and healthcare impacts